possible, these immunizations should be considered before starting an immunosuppressive therapy to optimize the immunological response. Furthermore, in Europe, live vaccines are completely contraindicated in patients with immunosuppressive therapy. 9 In the United States, therapy with low doses of methotrexate or thiopurines is not regarded as contraindication for administration of zoster vaccine. 10 In 2014, the European Crohn's and Colitis Organisation (ECCO) published their second consensus guidelines on the prevention, diagnosis, and management of opportunistic infections in IBD. 9 These guidelines recommended influenza vaccination for all patients on immunosuppressive therapy or older than 50 years and pneumococcal vaccination for patients under immunosuppressive therapy or for patients older than 65 years. Hepatitis B virus (HBV) vaccination is advised for all seronegative patients with IBD. Varicella zoster virus (VZV) vaccination is recommended for all immunoglobulin G-negative patients and before the introduction of immunosuppressive therapy. Tetanus, a routine vaccination, is recommended in all patients every 10 years. 11, 12 However, in the United States, guidelines are slightly different. Influenza vaccination is universally recommended to everyone older than 6 months, and HBV vaccination is optional if people are seronegative and have no risk factors. 10 Although this is already the second consensus article, many gastroenterologists have not yet adopted screening for preventable opportunistic infections nor have they implemented vaccination as part of their routine clinical practice in IBD. [13] [14] [15] [16] Besides, patients often report nonawareness as a major factor responsible for their low adherence to vaccination recommendations. 15 In recent publications, patient education regarding vaccinations, particularly among those who are receiving immunosuppressive therapies, has been identified as one of the 10 most highly rated process quality indicators in patients with IBD. [17] [18] [19] In this context, it is clear that increasing adherence rates to vaccination guidelines would lead to an improved quality of care and a decreased incidence of infectious morbidity in patients with IBD. Therefore, we investigated the current vaccination status in our IBD population and evaluated the efficacy of thorough education and information by an IBD nurse on further vaccination rates by implementing a simple quality improvement intervention. The impact of this thorough education program was compared with routine clinical practice.
METHODS

Patient Characteristics
Between December 2014 and March 2015, the vaccination status of 505 consecutive patients with IBD was collected by either a fellow in training or a certified gastroenterologist. The latter was a graduated gastroenterologist being part of the staff or working as a consultant in our hospital. Patients were recruited at the outpatient clinic of the Department of Gastroenterology and Hepatology of the University Hospitals Leuven, Belgium. The physician first completed a questionnaire for each patient indicating if a patient was vaccinated against influenza, pneumococcus, HBV, and tetanus and whether the patient had chickenpox in the past. In case the patient was unsure about previous immunization, serology was requested for HBV and VZV. Sociodemographic characteristics recorded were sex, age, IBD diagnosis (based on radiological, endoscopic, and histological findings), level of education (no schooling, craft, secondary, bachelor, and master), and current therapy (mesalamine, corticosteroids, thiopurines, methotrexate, anti-tumor necrosis factor agents, antiadhesion molecules, and other investigational medical products). Written informed consent was provided by all patients in the framework of the Institutional Review Board-approved Flemish inheritance study for Crohn's and colitis (VLECC; B322201213950/S53684).
Randomization
Patients were randomly assigned to 1 of 2 groups, but they were not aware of the 2 arms of the trial. Patients in group A received routine clinical care, meaning they were provided with a standard explanation on the importance of vaccination by the To control for the knowledge of vaccination guidelines of each individual physician, as well as for their mode of delivering this information to their patients, each physician was requested to refer half of their patients seen during each outpatient clinic to an IBD nurse for further education. These were the patients examined by the fellows in training between 8 AM and 10 AM and by the certified gastroenterologist between 10 AM and 12 PM.
Education and Information
Patients in intervention group B were referred to an IBD nurse for an individual 15 minutes nurse-patient contact. During this contact, previous immunizations were reviewed and recommended vaccinations were discussed with the patient. The patient was educated according to the international guidelines with help of an information brochure and vaccination card (see, Supplemental Digital Content 1, http://links.lww.com/IBD/B431) developed by the IBD nurse in close collaboration with the IBD staff. When requested by the patient, prescriptions were provided, and the general practitioner or IBD nurse administered appropriate vaccines.
Annual influenza vaccination was recommended for all patients on immunosuppressive therapy or patients older than 50 years and this until the end of January 2015. Vaccination rates for influenza were only analyzed for patients recruited during the vaccination season (December-January). Pneumococcal vaccination was recommended for all patients on immunosuppressive therapy or patients older than 65 years. A vaccination with PVC13 was advised, followed by a dose of PPSV23 at least 8 weeks later. A full vaccination course for HBV (0, 1, and 6 months) was recommended for all patients with IBD who had not received this yet. Starting the HBV vaccination schedule was considered as a positive action in this study. Data were collected regarding human papillomavirus in females only. However, human papillomavirus vaccination was not recommended in this education project because the guidelines are not consistent and most patients were already sexually active. Furthermore, since 2010, human papillomavirus vaccination has been standard for young females in Belgium. Ten-yearly vaccination with tetanus toxoid, a routine vaccination, was advised for all patients with IBD. In addition, extra attention was paid to the discussion of administration of live vaccines e.g., in patients planning to travel to yellow fever endemic areas. Vaccination for VZV, a live vaccine, was only advised for seronegative patients not receiving immunosuppressive therapy. Serology for VZV was only tested in patients in whom previous history of chickenpox was absent or unclear.
Follow-up
After 8 months, all patients in group A and intervention group B were contacted to check for actual vaccination history. Most of the patients were seen at the outpatient clinic within 8 months from baseline for follow-up. Otherwise patients (and general practitioners) were contacted by phone to verify current vaccination status.
Data Analysis
All statistical analyses were performed using the IBM SPSS 23.0 software packages (SPSS Inc., Chicago, IL). Descriptive statistics (median with interquartile range or percentage) were used to summarize the distributions of the characteristics in our patients. To identify predictors of better adherence to vaccination recommendations, univariate and multivariate logistic regression analyses were conducted to evaluate the odds ratios of various risk factors associated with low adherence to vaccination guidelines in patients with IBD (represented as odds ratio with 95% confidence interval). Univariate analyses included chi-square and Mann--Whitney U statistics. Multivariate analyses were performed using binary logistic regression to define independent predictors of low adherence to vaccination guidelines. A P value ,0.050 was considered significant.
RESULTS
Baseline Status
Patient Characteristics
Data were collected for all 505 interviewed patients with IBD, giving a response rate of 100%. Of the 505 patients with IBD (53% men, median age 44 years), 365 (72%) patients had Crohn's disease, 134 (27%) had ulcerative colitis, and 6 (1%) had IBD type unclassified. A total of 238 patients (47%) had a high educational level, defined as having a bachelor or master degree. Regarding medical therapy, 340 patients (67%) were on immunosuppressive therapy (corticosteroids, thiopurines, methotrexate, biological therapy, or a combination of the foregoing) and 49% (247/505) of the patients were seen by a fellow in training (Table 1) .
Vaccination Rates
Analysis of the baseline vaccination status demonstrated that 80% (403/505) of the patients were vaccinated according to the recommendations for influenza, 62% (312/505) for pneumococcus, 53% (265/505) for HBV, and 82% (416/505) for tetanus. Overall, 159 (32%) of the 505 patients were completely vaccinated according to the guidelines (Fig. 1) . Because 86% (434/505) of patients declared previous exposure to VZV, the effect of varicella vaccination was not further explored. Furthermore, more than 95% of the adult Belgian population has antibodies to VZV. 20 
Status After Randomization
Patient Characteristics
Of the 505 patients included in the study, 346 (69%) were not vaccinated according to the guidelines. Of these patients, 206 (60%) were randomized to group A and 140 (40%) to intervention group B. Twenty-eight patients who were actually randomized to intervention group B and referred for further education did not wait for their contact with the IBD nurse. Therefore, these patients were included in group A for further analysis. Of the 28 patients who did not wait to see the nurse, 12 (43%) were seen by a fellow in training and 16 (57%) by a certified gastroenterologist (P ¼ 0.52). Patients randomized to intervention group B were more often using immunosuppressive therapy (P ¼ 0.044) and more often examined by a certified gastroenterologist (P , 0.001). All other variables were equally distributed between both groups (Table 2) .
Vaccination Rates
After 8 months, vaccination rates were significantly higher in intervention group B compared with group A. Namely, 36% (18/50) versus 10% (5/52) for influenza (P ¼ 0.001), 62% (53/86) versus 23% (25/107) for pneumococcus (P , 0.001), 27% (24/89) versus 5% (7/151) for HBV (P , 0.001), and 33% (11/33) versus 2% (1/56) for tetanus (P, 0.001). Overall, 33% (46/140) of the patients in intervention group B versus 6% (13/206) in group A had adhered to all vaccination recommendations 8 months after randomization (P , 0.001) (Fig. 2) . The absolute improvement of 27% results in a number needed to treat of 3.7.
Univariate and Multivariate Analysis in All Randomized Patients
Univariate Analysis
In univariate analysis, a higher educational level was associated with compliance with pneumococcus vaccine 
Multivariate Analysis
In multivariate analysis, having a higher educational level was associated with better compliance with vaccination guidelines for pneumococcus (2.39 [1.26-4.55], P ¼ 0.008) and the complete vaccination schedule (4.73 [2.42-9.21], P , 0.001). However, additional education and information by an IBD nurse was the only consistent factor associated with improved compliance with vaccination guidelines for each of the vaccines individually (Table 3) . Patients who had received additional education and information by an IBD nurse were 7.38 (95% confidence interval: 3.67-14.76) times more compliant with vaccination guidelines 8 months after randomization.
Complete Vaccination After 8 Months
In addition, we analyzed the influence of the number of missing recommended vaccines on complete vaccination. In both groups, complete vaccination was influenced by the number of missing recommended vaccines. Patients who needed more interventions to fulfill vaccination guidelines, more often were not completely vaccinated after 8 months.
DISCUSSION
Prevention of opportunistic and serious infections is an important issue in the disease management of patients with IBD, especially those on immunosuppressive therapy. This study implemented thorough vaccination education and information by an IBD nurse with the help of an information brochure and vaccination card (see Supplemental Digital Content 1, http://links.lww.com/IBD/ B431) and identified significant changes in vaccination behavior for all vaccines based on this intervention. Results of the baseline survey showed that vaccination was not considered as often as it should be. Furthermore, our study demonstrated that a thorough vaccination education was more effective than daily clinical practice.
Previous studies reported low adherence to screening and vaccination guidelines, ranging from 3 to 62% depending on the type of vaccination. 15, 21 Analysis of the baseline status of our patients with IBD showed comparable results. Only one-third of the interviewed patients were completely vaccinated according to the ECCO guidelines published in 2010. 9 These data confirm that compliance with vaccination recommendations is far from optimal in the IBD population.
Nevertheless, recent publications indicated education about appropriate and inappropriate vaccinations in immunosuppressed patients with IBD as 1 of the 10 most important process quality indicators in IBD. 17, 18 By implementing a simple intervention, we improved vaccination rates in our population and provided patients with a better level of quality of care, and as a result, we expect to see improved patient outcomes.
Recently, Parker et al 22 proved that by introducing a PlanDo-Study-Act quality improvement model in 184 patients, vaccination rates improved significantly. Huth et al and Reich et al described in 2015 that introducing an educational intervention was associated with improved influenza and pneumococcus vaccination rates in patients with IBD. 23, 24 Our study confirmed these findings. By providing patients with thorough education and information, a significant increase in vaccination rates of approximately 30% was achieved for all vaccines.
Two other improvement projects showed similar increases in vaccination rates. 25, 26 However, these studies focused on the association of systematic information for health care providers and adherence to vaccination guidelines instead of on a quality improvement project on patients' level.
Multivariate analysis identified a higher educational level as being independently associated with improved compliance with vaccination guidelines for pneumococcus and the full vaccination schedule. This could be explained by the fact that most of the recommended vaccines, especially those for pneumococcus and hepatitis, are expensive and not reimbursed for patients with IBD in Belgium. We assume that patients with a higher educational level have a higher median annual income.
Of note, additional education and information by an IBD nurse was the only consistent factor associated with better compliance with vaccination guidelines for all vaccines. The use of an information brochure, in understandable language, and additional education during a nurse-patient contact significantly increased compliance with vaccination recommendations. In future projects, we can implement similar tools to create a positive change around other process quality indicators and as a result further improve disease outcome and quality of care.
Patients randomized to intervention group B were more often using immunosuppressive therapy, and the use of immunosuppressive therapy was identified as a predictor of improved compliance with vaccination guidelines in univariate analysis. However, we assume that the use of immunosuppressants has not favored the higher vaccination rates in intervention group B as the vaccination guidelines are more extensive for patients using immunosuppressive therapy.
Despite the positive effect of the educational intervention, vaccination rates are still far from optimal, and we conclude that there is still an unmet need for further education of both patients and health care providers. Possible reasons for low adherence are the out-of-pocket costs of vaccines and the skepticism or low-perceived utility by patients toward vaccination. Results are presented as odds ratio (95% confidence interval). NS, not significant.
Our study also has some limitations. First of all, recall or response bias may have been present, as in all studies based on collection of questionnaires. However, the influence of recall bias should have been equal in both the control and the intervention groups. We have tried to minimize this by performing baseline serology for HBV and VZV in cases where the patient did not remember. Second, vaccination status after randomization was only based on the information we received from patients and their general practitioners, we did not check for serum titers. Furthermore, we did not interview patients personally for reasons associated with no adherence to vaccination recommendations, such as costs, skepticism, fear for adverse events,.. Besides, patients were recruited between December and March, being at the end of and after the vaccination season for influenza. By only including patients recruited in December and January for the analysis of influenza recommendation uptake, we minimized for this deficiency. In addition, 28 patients did not wait for the IBD nurse for further education, resulting in a difference in patient numbers between groups A and B. Possibly, these patients are the least motivated for education and pulled down the results in group A.
Finally, 3 important strengths of this study should be mentioned. First, we interviewed a large and diverse patient population, considered to be representative of the Belgian IBD population. Second, all patients were contacted for follow-up on the actual vaccination history, giving a very high participation rate virtually excluding selection bias. And third, patients were included simultaneously in both groups, minimizing for confounders.
We conclude that low compliance with vaccination recommendations in patients with IBD can be improved by providing the patients with thorough education and information. Introduction of an easily accessible and inexpensive intervention immediately resulted in markedly increased vaccination rates. This study demonstrates that a simple educational intervention is able to induce a positive change around an important process quality indicator. In the future, such measures can be implemented for other quality indicators, resulting in a better quality of care and improved patient outcomes.
